Position in MLYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$283,290
-$1,155 QoQ
Shares Held
10,500
0.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#158
of 224 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lion Point Capital, LP holds $18,132,915 across 30 Biotechnology names. MLYS ranks #23 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CUE |
Cue Biopharma, Inc.
|
52,928 | $1,670,407 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
4,450 | $1,489,815 | |
| 3 | MLTX |
MoonLake Immunotherapeutics
|
67,500 | $1,314,225 | |
| 4 | FENC |
Fennec Pharmaceuticals Inc.
|
112,434 | $1,208,665 | |
| 5 | RPRX |
Royalty Pharma plc
|
21,400 | $1,199,898 | |
| 6 | MIST |
Milestone Pharmaceuticals Inc.
|
820,000 | $1,098,800 | |
| 7 | BNTC |
Benitec Biopharma Inc.
|
62,000 | $829,560 | |
| 8 | SNDX |
Syndax Pharmaceuticals Inc
|
36,000 | $786,960 |
All Filings in MLYS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $283,290 | 10,500 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $284,445 | 10,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $381,045 | 10,500 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,478,880 | 39,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,068,870 | 79,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,254,520 | 79,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $972,490 | 79,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $956,690 | 79,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $924,300 | 79,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $774,600 | 60,000 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||